Evaluation of a New Oral Contrast Agent for MR Enterography in the Assessment of Crohn Disease in the Small Bowel

Completed

Conditions studied: Crohn Disease

In brief

The purpose of this study is to assess the exam quality and accuracy of MR using a new oral contrast agent for the evaluation of Crohn Disease in the small bowel.

Key facts

Study ID

NCT00587210

Run by

Mayo Clinic

People needed

34

Starts

2004-06-01

Expected to finish

2008-12-01

Last updated by the study team

2016-01-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Known or suspected Crohn Disease
• Undergoing colonoscopy and CT enterography

You may not qualify if…

• Contraindication to MR

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.